Article
Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.
Psycho-oncology - 1 Jan 2000
Julian-Reynier C, Sobol H, Sévilla C, Noguès C, Bourret P
Abstract excerpt
Due to the technical difficulties involved in identifying BRCA1/2 genetic mutations, the affected patients have to be investigated before testing can be made available to all the relatives at risk. Here, we studied the attendance rates at cancer genetic clinics (CGC) and the uptake of genetic testing in first/second degree relatives after the first BRCA1 mutated woman with cancer had been informed in the family....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
